Lindsay Androski - Jul 1, 2022 Form 4 Insider Report for Eloxx Pharmaceuticals, Inc. (ELOX)

Role
Director
Signature
/s/ Sumit Aggarwal, Attorney-in-Fact for Lindsay Androski
Stock symbol
ELOX
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
4
Date filed
7/6/2022, 09:50 PM
Next filing
Jan 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELOX Stock Options (Right to Buy) Award $0 +40K $0.00 40K Jul 1, 2022 Common Stock 40K $0.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 50% of the underlying shares on July 1, 2023 and the remainder in twelve (12) equal monthly installments thereafter.